Cargando...
Polypharmacy Increases Risk of Dyspnea Among Adults With Serious, Life-Limiting Diseases
BACKGROUND: Polypharmacy is associated with dyspnea in cross-sectional studies, but associations have not been determined in longitudinal analyses. Statins are commonly prescribed but their contribution to dyspnea is unknown. We determined whether polypharmacy was associated with dyspnea trajectory...
Guardado en:
| Publicado en: | Am J Hosp Palliat Care |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8318598/ https://ncbi.nlm.nih.gov/pubmed/31550901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1049909119877512 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|